CHU Brest / Hôpital Morvan
- Address
- 2 avenue Foch, Brest, France
Anesthesia and Analgesia in Neonates
The department is evaluating innovative pain‑relief strategies for premature infants, aiming to reduce opioid exposure while supporting breathing comfort. The study compares continuous dexmedetomidine infusion with placebo in ventilated neonates experiencing neonatal respiratory distress.
- Continuous infusion of dexmedetomidine
- Opioid‑sparing analgesic protocols
- Impact on ventilation duration and cumulative opioid dose
Conducted at CHU Brest / Hôpital Morvan, the research seeks safer sedation options for the most vulnerable newborns.
Congenital and Neonatal Diseases
Focused on early‑life respiratory challenges, this program studies infants with neonatal respiratory distress to improve diagnostic accuracy and therapeutic techniques. The goal is to enhance survival and long‑term health of newborns through refined care pathways.
- Optimization of ventilatory support settings
- Development of non‑invasive monitoring tools
- Early identification of high‑risk respiratory patterns
The initiative aligns with the unit’s commitment to advance care for congenital and hereditary conditions in the neonatal period.
Immune System Diseases in Pediatric Oncology
A multicenter French protocol investigates treatment schedules for children and adolescents with standard or medium‑risk acute lymphoblastic leukemia. Using pegaspargase, the trial assesses pharmacokinetic superiority and tolerability across different induction schemes.
- Pharmacokinetic profiling at Day 33
- Equivalence of toxicity between fractionated and intensified regimens
- Stratification by immunophenotypic risk groups
This research, part of the CAALL‑F01 study, aims to refine therapeutic approaches for pediatric immune system malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU Brest / Hôpital Morvan
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Dexmedetomidine vs Placebo on Cumulative Opioid Consumption in Premature Neonates Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial | Centre Hospitalier Intercommunal Creteil | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexmedetomidine | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.